Second-generation antipsychotics and the risk of chronic kidney disease: a population-based case-control study.
Mikkel HojlundLars Christian LundJonas Leander Emming HerpingMaija Bruun HaastrupPer DamkierDaniel Pilsgaard HenriksenPublished in: BMJ open (2020)
Use of SGA is associated with a small-to-moderately increased risk of incident CKD. All investigated SGAs, except for aripiprazole, were associated with an increased risk of CKD.